Trial intelligence / Profile preview

CBD, amitriptyline and tramadol drug-drug interaction study

NL-OMON60108Phase 2Completed

Sponsor
Centre for Human Drug Research
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of cannabidiol, amitriptyline and tramadol, sponsored by Centre for Human Drug Research. Started Dec 2023; status: completed.

02

Drugs

cannabidiolamitriptylinetramadol

Beyond the preview

Go deeper on NL-OMON60108.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON60108.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call